Literature DB >> 7982920

Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity.

A Pandey1, D F Lazar, A R Saltiel, V M Dixit.   

Abstract

The Eph/Eck subfamily of receptor protein tyrosine kinases is currently the largest subfamily of receptor protein tyrosine kinases with a dozen members (Van der Geer, P., Hunter, T., and Lindberg, R. A. (1994) Annu. Rev. Cell Biol. 10, 251-337). Using the cytoplasmic domain of Eck as bait in a yeast two-hybrid screen of mouse embryonic and T-cell cDNA libraries, it was discovered that the p85 subunit of phosphatidylinositol 3-kinase bound Eck. Further, using glutathione S-transferase fusion proteins, it was found that the C-terminal src homology 2 domain of the p85 subunit specifically interacted with Eck. Additionally, Eck coimmunoprecipitated with p85 in ligand activated cells confirming their interaction in vivo. In keeping with the above observations, activation of Eck by its ligand, B61, increased phosphatidylinositol 3-kinase activity. This is the first description of a signal transduction pathway initiated by any member of the Eph/Eck family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982920

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner.

Authors:  C Gu; S Park
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Authors:  Nicolas Prevost; Donna Woulfe; Takako Tanaka; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 3.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

4.  Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.

Authors:  Masamitsu Tanaka; Riuko Ohashi; Ritsuko Nakamura; Kazuya Shinmura; Takaharu Kamo; Ryuichi Sakai; Haruhiko Sugimura
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

Review 5.  Eph and ephrin signaling in mammary gland morphogenesis and cancer.

Authors:  Anne-Catherine Andres; Andrew Ziemiecki
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

6.  PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.

Authors:  B Hock; B Böhme; T Karn; T Yamamoto; K Kaibuchi; U Holtrich; S Holland; T Pawson; H Rübsamen-Waigmann; K Strebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.

Authors:  Scott M Thompson; Danielle E Jondal; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Matthew P Stokes; Xiaoying Jia; Joseph P Grande; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Int J Hyperthermia       Date:  2017-11-06       Impact factor: 3.914

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

10.  Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  Thromb Res       Date:  2008-09-03       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.